Michael Reiss

Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer

Journal of Clinical Oncology · 2006 · 883 citations

Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGFβ) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma

PLoS ONE · 2014 · 414 citations